Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise: Responses of molecular mass variants

William J. Kraemer, Bradley C. Nindl, Jeff S. Volek, James O. Marx, Lincoln A. Gotshalk, Jill A. Bush, Jill R. Welsch, Jakob L. Vingren, Barry A. Spiering, Maren S. Fragala, Disa L. Hatfield, Jen Yu Ho, Carl M. Maresh, Andrea M. Mastro, Wesley C. Hymer

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The purpose was to examine effects of oral contraceptive (OC) use on plasma growth hormone (GH) responses to heavy resistance exercise. Sixty untrained women were placed into one of two groups: currently using OC (Ortho Tri-Cyclen®) (n = 25; mean ± SD: 24.5 ± 4.2 y, 160.4 ± 7.1 cm, 64.1 ± 11.3 kg) or not currently using OC (NOC) (n = 35; 23.6 ± 4.6 y, 165.9 ± 6.0 cm, 65.7 ± 10.3 kg). Participants performed an acute heavy resistance exercise test (AHRET; six sets of 10 repetition squats; 2 min rest between sets) during days 2-4 of the follicular phase (NOC group) or of inactive oral contraceptive intake (OC group). Plasma was obtained before and immediately after AHRET and subsequently fractionated based on apparent molecular weight (>60 kD, 30-60 kD, and <30 kD). GH was determined in unfractionated plasma and each plasma fraction using 4 methods: (1) Nichols Institute Diagnostics immunoradiometric assay (Nichols), (2) National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) competitive radioimmunoassay, (3) DSL immunofunctional enzyme-linked immunoabsorbent assay (IFA) and (4) rat tibial line bioassay. GH increased (P < 0.05) in all fractions post-AHRET for the Nichols, NIDDK, and IFA. The OC group displayed higher resting GH for the NIDDK, and higher exercise-induced GH for the IFA, Nichols, and NIDDK in unfractionated plasma and >60 kD subfraction compared to NOC group. No differences were observed for the tibial line bioassay. OC use augmented immunological GH response to AHRET in unfractionated plasma and >60 kD molecular weight subfraction. However, OC use only increased biological activity of GH in one of two bioassays. These data demonstrated that GH concentrations at rest and following exercise are assay-dependent.

Original languageEnglish
Pages (from-to)238-244
Number of pages7
JournalGrowth Hormone and IGF Research
Volume18
Issue number3
DOIs
Publication statusPublished - 2008 Jun 1

Fingerprint

Oral Contraceptives
Growth Hormone
Exercise
Biological Assay
Molecular Weight
Follicular Phase
Exercise Test

Keywords

  • Birth control
  • Estradiol
  • Reproductive hormones
  • Strength
  • Women

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise : Responses of molecular mass variants. / Kraemer, William J.; Nindl, Bradley C.; Volek, Jeff S.; Marx, James O.; Gotshalk, Lincoln A.; Bush, Jill A.; Welsch, Jill R.; Vingren, Jakob L.; Spiering, Barry A.; Fragala, Maren S.; Hatfield, Disa L.; Ho, Jen Yu; Maresh, Carl M.; Mastro, Andrea M.; Hymer, Wesley C.

In: Growth Hormone and IGF Research, Vol. 18, No. 3, 01.06.2008, p. 238-244.

Research output: Contribution to journalArticle

Kraemer, WJ, Nindl, BC, Volek, JS, Marx, JO, Gotshalk, LA, Bush, JA, Welsch, JR, Vingren, JL, Spiering, BA, Fragala, MS, Hatfield, DL, Ho, JY, Maresh, CM, Mastro, AM & Hymer, WC 2008, 'Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise: Responses of molecular mass variants', Growth Hormone and IGF Research, vol. 18, no. 3, pp. 238-244. https://doi.org/10.1016/j.ghir.2007.10.001
Kraemer, William J. ; Nindl, Bradley C. ; Volek, Jeff S. ; Marx, James O. ; Gotshalk, Lincoln A. ; Bush, Jill A. ; Welsch, Jill R. ; Vingren, Jakob L. ; Spiering, Barry A. ; Fragala, Maren S. ; Hatfield, Disa L. ; Ho, Jen Yu ; Maresh, Carl M. ; Mastro, Andrea M. ; Hymer, Wesley C. / Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise : Responses of molecular mass variants. In: Growth Hormone and IGF Research. 2008 ; Vol. 18, No. 3. pp. 238-244.
@article{ebb3a28a851745749ac43c4bebb5c4a6,
title = "Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise: Responses of molecular mass variants",
abstract = "The purpose was to examine effects of oral contraceptive (OC) use on plasma growth hormone (GH) responses to heavy resistance exercise. Sixty untrained women were placed into one of two groups: currently using OC (Ortho Tri-Cyclen{\circledR}) (n = 25; mean ± SD: 24.5 ± 4.2 y, 160.4 ± 7.1 cm, 64.1 ± 11.3 kg) or not currently using OC (NOC) (n = 35; 23.6 ± 4.6 y, 165.9 ± 6.0 cm, 65.7 ± 10.3 kg). Participants performed an acute heavy resistance exercise test (AHRET; six sets of 10 repetition squats; 2 min rest between sets) during days 2-4 of the follicular phase (NOC group) or of inactive oral contraceptive intake (OC group). Plasma was obtained before and immediately after AHRET and subsequently fractionated based on apparent molecular weight (>60 kD, 30-60 kD, and <30 kD). GH was determined in unfractionated plasma and each plasma fraction using 4 methods: (1) Nichols Institute Diagnostics immunoradiometric assay (Nichols), (2) National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) competitive radioimmunoassay, (3) DSL immunofunctional enzyme-linked immunoabsorbent assay (IFA) and (4) rat tibial line bioassay. GH increased (P < 0.05) in all fractions post-AHRET for the Nichols, NIDDK, and IFA. The OC group displayed higher resting GH for the NIDDK, and higher exercise-induced GH for the IFA, Nichols, and NIDDK in unfractionated plasma and >60 kD subfraction compared to NOC group. No differences were observed for the tibial line bioassay. OC use augmented immunological GH response to AHRET in unfractionated plasma and >60 kD molecular weight subfraction. However, OC use only increased biological activity of GH in one of two bioassays. These data demonstrated that GH concentrations at rest and following exercise are assay-dependent.",
keywords = "Birth control, Estradiol, Reproductive hormones, Strength, Women",
author = "Kraemer, {William J.} and Nindl, {Bradley C.} and Volek, {Jeff S.} and Marx, {James O.} and Gotshalk, {Lincoln A.} and Bush, {Jill A.} and Welsch, {Jill R.} and Vingren, {Jakob L.} and Spiering, {Barry A.} and Fragala, {Maren S.} and Hatfield, {Disa L.} and Ho, {Jen Yu} and Maresh, {Carl M.} and Mastro, {Andrea M.} and Hymer, {Wesley C.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1016/j.ghir.2007.10.001",
language = "English",
volume = "18",
pages = "238--244",
journal = "Growth Hormone and IGF Research",
issn = "1096-6374",
publisher = "Elsevier Ltd",
number = "3",

}

TY - JOUR

T1 - Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise

T2 - Responses of molecular mass variants

AU - Kraemer, William J.

AU - Nindl, Bradley C.

AU - Volek, Jeff S.

AU - Marx, James O.

AU - Gotshalk, Lincoln A.

AU - Bush, Jill A.

AU - Welsch, Jill R.

AU - Vingren, Jakob L.

AU - Spiering, Barry A.

AU - Fragala, Maren S.

AU - Hatfield, Disa L.

AU - Ho, Jen Yu

AU - Maresh, Carl M.

AU - Mastro, Andrea M.

AU - Hymer, Wesley C.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - The purpose was to examine effects of oral contraceptive (OC) use on plasma growth hormone (GH) responses to heavy resistance exercise. Sixty untrained women were placed into one of two groups: currently using OC (Ortho Tri-Cyclen®) (n = 25; mean ± SD: 24.5 ± 4.2 y, 160.4 ± 7.1 cm, 64.1 ± 11.3 kg) or not currently using OC (NOC) (n = 35; 23.6 ± 4.6 y, 165.9 ± 6.0 cm, 65.7 ± 10.3 kg). Participants performed an acute heavy resistance exercise test (AHRET; six sets of 10 repetition squats; 2 min rest between sets) during days 2-4 of the follicular phase (NOC group) or of inactive oral contraceptive intake (OC group). Plasma was obtained before and immediately after AHRET and subsequently fractionated based on apparent molecular weight (>60 kD, 30-60 kD, and <30 kD). GH was determined in unfractionated plasma and each plasma fraction using 4 methods: (1) Nichols Institute Diagnostics immunoradiometric assay (Nichols), (2) National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) competitive radioimmunoassay, (3) DSL immunofunctional enzyme-linked immunoabsorbent assay (IFA) and (4) rat tibial line bioassay. GH increased (P < 0.05) in all fractions post-AHRET for the Nichols, NIDDK, and IFA. The OC group displayed higher resting GH for the NIDDK, and higher exercise-induced GH for the IFA, Nichols, and NIDDK in unfractionated plasma and >60 kD subfraction compared to NOC group. No differences were observed for the tibial line bioassay. OC use augmented immunological GH response to AHRET in unfractionated plasma and >60 kD molecular weight subfraction. However, OC use only increased biological activity of GH in one of two bioassays. These data demonstrated that GH concentrations at rest and following exercise are assay-dependent.

AB - The purpose was to examine effects of oral contraceptive (OC) use on plasma growth hormone (GH) responses to heavy resistance exercise. Sixty untrained women were placed into one of two groups: currently using OC (Ortho Tri-Cyclen®) (n = 25; mean ± SD: 24.5 ± 4.2 y, 160.4 ± 7.1 cm, 64.1 ± 11.3 kg) or not currently using OC (NOC) (n = 35; 23.6 ± 4.6 y, 165.9 ± 6.0 cm, 65.7 ± 10.3 kg). Participants performed an acute heavy resistance exercise test (AHRET; six sets of 10 repetition squats; 2 min rest between sets) during days 2-4 of the follicular phase (NOC group) or of inactive oral contraceptive intake (OC group). Plasma was obtained before and immediately after AHRET and subsequently fractionated based on apparent molecular weight (>60 kD, 30-60 kD, and <30 kD). GH was determined in unfractionated plasma and each plasma fraction using 4 methods: (1) Nichols Institute Diagnostics immunoradiometric assay (Nichols), (2) National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) competitive radioimmunoassay, (3) DSL immunofunctional enzyme-linked immunoabsorbent assay (IFA) and (4) rat tibial line bioassay. GH increased (P < 0.05) in all fractions post-AHRET for the Nichols, NIDDK, and IFA. The OC group displayed higher resting GH for the NIDDK, and higher exercise-induced GH for the IFA, Nichols, and NIDDK in unfractionated plasma and >60 kD subfraction compared to NOC group. No differences were observed for the tibial line bioassay. OC use augmented immunological GH response to AHRET in unfractionated plasma and >60 kD molecular weight subfraction. However, OC use only increased biological activity of GH in one of two bioassays. These data demonstrated that GH concentrations at rest and following exercise are assay-dependent.

KW - Birth control

KW - Estradiol

KW - Reproductive hormones

KW - Strength

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=41649094999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649094999&partnerID=8YFLogxK

U2 - 10.1016/j.ghir.2007.10.001

DO - 10.1016/j.ghir.2007.10.001

M3 - Article

C2 - 18037316

AN - SCOPUS:41649094999

VL - 18

SP - 238

EP - 244

JO - Growth Hormone and IGF Research

JF - Growth Hormone and IGF Research

SN - 1096-6374

IS - 3

ER -